Skip to Content

Money meets innovation at Biotech Showcase 2011

Event doubles in size over 2010 edition

CARLSBAD, Calif. & NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Jan 20, 2011 - For professional investors and biopharma dealmakers Biotech Showcase™ was where exciting companies with novel products could be found during the annual gathering of healthcare investors. Held last week at Parc 55 Wyndham San Francisco – Union Square, the third annual Biotech Showcase event doubled in size over the 2010 edition, attracting more than 1,300 delegates. The event also featured a full program of workshops, three lunch plenary sessions, and corporate presentations from 195 companies. More in-depth coverage of the program can be found at

“Biotech Showcase is where money meets innovation. While other events cater to large-cap biomedical and healthcare firms, Biotech Showcase is focused on emerging innovator companies,” said Carola Schropp, President of EBD Group. “For VCs and pharma dealmakers this class of company is where tomorrow's revenue and profit are to be found.”

“The rapid growth of Biotech Showcase demonstrates that there is a high demand for an event that focuses on emerging private and public life science companies seeking exposure to potential investors and business development executives who gather in San Francisco each January,” said Sara Jane Demy, Principal of Demy-Colton Life Science Advisors. “Biotech Showcase is where you will find the innovative companies that will propel this industry forward.”

Dennis Purcell, Managing Director of Aisling Capital, remarked, “Biotech Showcase should change its name to H&Q 2.0, after all, it is what H&Q used to be. This is where the innovators are, and new investment opportunities can be found.”

Rob Neville, CEO of Savara Pharmaceuticals, who presented at Biotech Showcase, added, “As a company on the leading edge of pulmonary therapeutics, we believe that Savara is an exciting investment opportunity. Being registered at Biotech Showcase increased web traffic by 25% and was a real catalyst to our investment/fundraising goals. We had about 10 one-to-one meetings with credible institutions with some strong investment interest.”

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations, and include:


  • BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group's consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information visit

About Demy-Colton Life Science Advisors

Demy-Colton is focused exclusively on facilitating the growth of the life science industry. Sara Jane Demy, the principal of Demy-Colton, is a leader at designing and developing high-value added programs and services to address the business needs of the biotechnology industry.


Contact: EBD Group
Constantine Theodoropulos, +1 617-401-3116
Demy Colton Life Science Advisors
Sara Jane Demy, +1 917-902-4148



Posted: January 2011